Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
Interest Income Expense
Shandong Pharmaceutical Glass Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Interest Income Expense
¥60.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Interest Income Expense
-¥196.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Interest Income Expense
¥109.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
89%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Interest Income Expense
¥236.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Interest Income Expense
¥110.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Interest Income Expense
¥733m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
107%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Interest Income Expense?
Interest Income Expense
60.4m
CNY
Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Interest Income Expense amounts to 60.4m CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
3%
Over the last year, the Interest Income Expense growth was 25%. The average annual Interest Income Expense growth rates for Shandong Pharmaceutical Glass Co Ltd have been 29% over the past three years , 3% over the past five years .